2 Result: Nasdaq:CRBU
Analysts: CRBU, SOPA, SNDX, TOST, BLFS, CMC, HVT, NWL, HLMN are a Buy
July 12th, 2023
Caribou Biosciences, Inc. (Nasdaq: CRBU), a company that operates in the field of genome editing and develops CRISPR-based technologies for various applications, was initiated with a Buy rating by Truist, accompanied by a price target of $23. . Read more
Market Surge: Mullen Gains Momentum, Pfizer's Investment Fuels Caribou Biosciences
July 06th, 2023
Shares of Mullen Automotive, Inc. (Nasdaq: MULN) surged over 60% in pre-market trading after the company announced a $25 million stock buyback program authorized through December 31, 2023. Mullen believes that its stock is significantly undervalue. Read more
Load More Content
Want To Find Some News?
News By Industries
Recent Post
-
February 27th, 2026February 26th, 2026
Member Login